Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: An evaluation by polymerase chain reaction

Journal of Clinical Pathology

Volumn 50, Issue 12, 1997, Pages 1018-1021

  Chan, K W ^a,b   Wong, K Y ^a   Srivastava, G ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Human papillomavirus; Inverted papilloma; Transitional cell carcinoma

Indexed keywords

ARTICLE; BLADDER TUMOR; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; PAPILLOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR CLASSIFICATION; VIRUS CARCINOGENESIS; VIRUS DETECTION;

EID: 0031438460     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.12.1018     Document Type: Article

References (21)

1. Lazarevie B, Garret R. Inverted papilloma and papillary transitional cell carcinoma of urinary bladder. Report of four cases of inverted papilloma, one showing papillary malignant transformation and review of the literature. Cancer 1978;42:1904-11.
2. Anderstrom C, Johansson S, Pattersson S. Inverted papilloma of the urinary tract. J Urol 1982;127:1132-4.
3. Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol 1991;68:49-52.
4. Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992;70:1967-73.
5. Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR. Human papillomavirus associated with bladder cancer. Urology 1992;40:15-17.
6. Yu ST, Wu MM, Li LM. Prevalence of human papillomaviruses 16 and 18 in transitional cell carcinoma of bladder. Chin Med J Engl 1993;106:494-6.
7. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N, Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 1993;53:4823-7.
8. Kamel D, Paakko P, Pollanen R, Vahakangas K, Lehto VP, Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 1995;103:331-8.
9. Lopez Beltran A, Munoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 1995;26:565-9.
10. Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R, et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 1996;178;65-70.
11. Chan KW, Lam KY, Srivastava G. Accumulation of p53 protein in inverted transitional cell papilloma of urinary bladder. J Clin Pathol: Mol Pathol 1996;49:M43-5.
12. Chan KW, Lam KY, Chan ACL, Lau P, Srivastava G. Prevalence of human papillomavirus types 16 and 18 in penile carcinoma: a study of 41 cases using PCR. J Clin Pathol 1994;47:823-6.
13. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
14. Van Den Brule AJ, Walboomers JM, Du Maine M, Kenemans P, Meijer CJ. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 1991;48: 404-8.
15. Young LS, Bevan IS, Johnson MA, Blomfield PI, Bromidge T, Maitland NJ, et al. The polymerase chain reaction: a new epidemiological tool for investigating cervical human papillomavirus infection. BMJ 1989;298:14-18.
16. Tidy JA, Farrell PJ, Vousden KH. Relation between infection with a subtype of HPV16 and cervical neoplasia. Lancet 1989;i:1225-7.
17. Nyan HY, Stanley M, Liu SS, Ma HK. HPV and p53 in cervical cancer. Genitourin Med 1994;70:167-70.
18. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
19. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
20. Scheffner M, Werness B, Huibregtse JM, Levine AJ, Howley PM. The EG oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
21. Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD. Oncogene association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Ints 1987;79:671-7